Literature DB >> 24489558

Respiratory infection and otitis media visits in relation to pneumococcal conjugate vaccine use in Saskatchewan.

Ngoc-Hang Khuc1, Ben Tan2, Rosalie Tuchscherer3, Nigel Sb Rawson4, Philippe De Wals5.   

Abstract

BACKGROUND: In Saskatchewan, pneumococcal conjugate vaccination (PCV) was offered to high-risk children in 2002 and to all infants in 2005.
OBJECTIVE: To describe trends in the frequency of medical visits for lower respiratory tract infection (LRI) and otitis media (OM) in relation to PCV use during the period 1990 to 2008.
METHODS: Statistics regarding the number of children covered by the health insurance plan, PCV administration, and medical visits with a diagnostic code associated with LRI and OM were provided by Saskatchewan Health. Monthly rates were analyzed using dynamic state space models.
RESULTS: In all series, there was a marked seasonal cycle and some higher-than-expected winter peak values, possibly associated with epidemics of specific respiratory viruses. Three abrupt decreases in baseline rate were observed for LRI and the final one, in February 2007, could be related to the increased proportion of children vaccinated with PCV. There was no statistical correlation between PCV use and OM visit frequency.
CONCLUSION: Many environmental, biological and administrative factors may influence health services use, and an effect of low magnitude of a particular vaccine pertaining to nonspecific outcomes could be obscured in time-series analyses.

Entities:  

Keywords:  Otitis media; Pneumococcal conjugate vaccine; Pneumonia; Program evaluation

Year:  2013        PMID: 24489558      PMCID: PMC3904999          DOI: 10.1155/2013/385652

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  21 in total

1.  An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2002-01-15

Review 2.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

3.  25 years of pharmacoepidemiologic innovation: the Saskatchewan health administrative databases.

Authors:  Nigel S B Rawson; Winanne Downey; Colleen J Maxwell; Roy West
Journal:  J Popul Ther Clin Pharmacol       Date:  2011-05-02

Review 4.  Serotypes and pathogens in paediatric pneumonia.

Authors:  William P Hausdorff; Ron Dagan
Journal:  Vaccine       Date:  2008-06-16       Impact factor: 3.641

Review 5.  Epidemiological differences among pneumococcal serotypes.

Authors:  William P Hausdorff; Daniel R Feikin; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

6.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

7.  Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada.

Authors:  Philippe De Wals; Elodie Robin; Elise Fortin; Roseline Thibeault; Manale Ouakki; Monique Douville-Fradet
Journal:  Pediatr Infect Dis J       Date:  2008-11       Impact factor: 2.129

8.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Authors:  Steven B Black; Henry R Shinefield; Stella Ling; John Hansen; Bruce Fireman; David Spring; Jack Noyes; Edwin Lewis; Paula Ray; Janelle Lee; Jill Hackell
Journal:  Pediatr Infect Dis J       Date:  2002-09       Impact factor: 2.129

Review 9.  Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.

Authors:  Markus Rose; Stefan Zielen
Journal:  Expert Rev Vaccines       Date:  2009-10       Impact factor: 5.217

Review 10.  Impact of pneumococcal conjugate vaccination on otitis media: a systematic review.

Authors:  Sylvia Taylor; Paola Marchisio; Anne Vergison; Julie Harriague; William P Hausdorff; Mark Haggard
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.